Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication
Caroline G. Williams(Georgia State University), Christopher F. Basler(Icahn School of Medicine at Mount Sinai), Jennifer Oki, Stacie Chvatal(Axion Biosystems (United States)), Jesus A. Silvas(Texas Biomedical Research Institute), Kevin Holden(Synthego (United States)), Jared Carlson-Stevermer(Sunesis (United States)), Alexander S. Jureka(Centers for Disease Control and Prevention), Anthony M. Nicolini(Axion Biosystems (United States))
Cited by 124
Related Papers
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
|Science|2020|818
Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice
|Journal of Virology|2005|511
Taxonomy of the order Mononegavirales: update 2016
|Archives of Virology|2016|506
Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza
|Proceedings of the National Academy of Sciences|2002|375
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
|Nature Biotechnology|2021|375